Position in ABBV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$93,614,003
+$24,200,798 QoQ
Shares Held
430,429
+41.7% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 32.25990813815984.ToString("F0")%
Shared 0.ToString("F0")%
None 67.74009186184017.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital International, Inc./CA/ holds $919,638,265 across 11 Drug Manufacturers - General names. ABBV ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,009,997 | $396,411,608 | |
| 2 | LLY |
ELI LILLY & Co
|
193,029 | $177,542,283 | |
| 3 | AMGN |
Amgen Inc
|
398,069 | $140,060,577 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
430,429 | $93,614,003 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
355,956 | $49,609,587 | |
| 6 | JNJ |
Johnson & Johnson
|
156,815 | $38,331,858 | |
| 7 | PFE |
Pfizer Inc
|
374,286 | $10,509,950 | |
| 8 | NVO |
Novo Nordisk A S
|
155,415 | $5,711,501 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $93,614,003 | 430,429 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $69,413,205 | 303,791 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $55,652,491 | 240,358 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $32,009,426 | 172,446 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $66,521,342 | 317,494 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $73,015,508 | 410,892 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $77,984,654 | 394,899 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $70,304,504 | 409,891 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $70,260,007 | 385,832 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $46,282,100 | 298,652 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $34,282,160 | 229,989 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $25,713,220 | 190,850 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,170,375 | 44,992 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,537,856 | 52,830 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,772,773 | 50,464 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,032,323 | 52,444 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,376,645 | 26,998 | Shares | Defined | 2022-05-19 | |
| 2020-06-30 | $4,788,042 | 48,768 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,336,646 | 83,169 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||